Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Krebs Biochemicals & Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:524518 NSE Symbol: KREBSBIO P/E (TTM) :0
ISIN Demat:INE268B01013 Div & Yield %:0 EPS (TTM) :0
Book Value (RS) :-50.2613955 Market Cap (Rs Cr.):156.49 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2023)
Quarter Ended
(Dec 2022)
Quarter Ended
(% Var)
Sales 12.98 9.09 42.79
Other Income 0.03 0.02 50.00
PBIDT -2.06 -2.96 0.00
Interest 1.19 0.90 32.22
PBDT -3.25 -3.86 0.00
Depreciation 1.73 1.69 2.37
PBT -4.98 -5.55 0.00
Tax 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00
PAT -4.98 -5.55 0.00

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)